nmr suite professional software package (v8.1 Search Results


pclamp software  (Danaher Inc)
96
Danaher Inc pclamp software
Pclamp Software, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nmr+suite+professional+software+package+%28v8%2E1/pm14561467-34-0-3?v=Danaher+Inc
Average 96 stars, based on 1 article reviews
pclamp software - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier
nuclear magnetic resonance suite software v 8 1  (Chenomx Inc)
86
Chenomx Inc nuclear magnetic resonance suite software v 8 1
Nuclear Magnetic Resonance Suite Software V 8 1, supplied by Chenomx Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nmr+suite+professional+software+package+%28v8%2E1/pm40745196-44-6-12?v=Chenomx+Inc
Average 86 stars, based on 1 article reviews
nuclear magnetic resonance suite software v 8 1 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
imaris suite v 8 1 software  (Oxford Instruments)
99
Oxford Instruments imaris suite v 8 1 software
Imaris Suite V 8 1 Software, supplied by Oxford Instruments, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nmr+suite+professional+software+package+%28v8%2E1/pmc08477376-31-10-14?v=Oxford+Instruments
Average 99 stars, based on 1 article reviews
imaris suite v 8 1 software - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
chenomx nmr processor  (Chenomx Inc)
86
Chenomx Inc chenomx nmr processor
<t>NMR-based</t> metabolomic perturbation in NRK-52E cells after 96 h of PS-MPs treatment at low doses, 0.02, and high doses, 0.5 mg/mL. Control vs low doses: 0.02 mg/mL PS-MPs. (A) Representative 1 H NMR spectrum <t>of</t> <t>metabolites</t> extracted from control and PS-MPs (0.02 and 1 mg/mL) exposure. Control vs low doses: 0.02 mg/mL PS-MPs. (B) OPLS-DA of control (green color) and 0.02 mg/mL PS-MPs (red color). (C) Permutation test statistics with R2Y 0.99 and Q2 0.67. (D) The result of random forest classification with an out-of-bag (OOB) error of 0.33 and overall accuracy of 67% of control vs 0.02 mg/mL PS-MPs-treated groups. (E) VIP score plot. (F) Univariate analysis showing the significant metabolites in the control and PS-MPs (0.02 mg/mL)-treated group detected by 1 H NMR spectroscopy. The x -axis represents the metabolite, and the y -axis shows the relative concentration when control (represented by green color) and PS-MPs, 0.02 mg/mL (represented by red color), were compared. (G) Correlation heat map for the differential metabolites identified in the control vs PS-MPs (0.02 mg/mL) exposed group as calculated by z -scores. (H) Pathway analysis indicated an impact factor less than 0.1, thus not very significant. Control vs high doses: 0.5 mg/mL PS-MPs. (I) OPLS-DA of control (green color) and 0.5 mg/mL PS-MPs concentration (red color). (J) Permutation test statistics with R2Y 1 and Q2 0.59. (K) The result of random forest classification with an out-of-bag (OOB) error of 0.0 and an overall accuracy of 100% of control vs 0.5 mg/mL PS-MPs-treated groups (L) VIP score plot. (M) Univariate analysis showing the significant metabolites in the control and PS-MPs (0.5 mg/mL)-treated group detected by 1 H NMR spectroscopy. The x -axis represents the metabolite, and the y -axis represents the relative concentration when control (represented by green color) and PS-MPs (0.5 mg/mL, represented by red color) were compared. (N) Correlation heat map for the differential metabolites identified in control vs PS-MPs (0.5 mg/mL)-exposed group, as calculated by z-scores. (O) Pathway analysis showing an impact factor of more than 0.1 was considered. The top red one is phenylalanine, tyrosine, and tryptophan biosynthesis, and the other, with an impact factor between 0.2 and 0.4 is phenylalanine metabolism.
Chenomx Nmr Processor, supplied by Chenomx Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nmr+suite+professional+software+package+%28v8%2E1/pmc13280856-219-9-15?v=Chenomx+Inc
Average 86 stars, based on 1 article reviews
chenomx nmr processor - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
sigmaxl v8.1  (SigmaXL Inc)
90
SigmaXL Inc sigmaxl v8.1
<t>NMR-based</t> metabolomic perturbation in NRK-52E cells after 96 h of PS-MPs treatment at low doses, 0.02, and high doses, 0.5 mg/mL. Control vs low doses: 0.02 mg/mL PS-MPs. (A) Representative 1 H NMR spectrum <t>of</t> <t>metabolites</t> extracted from control and PS-MPs (0.02 and 1 mg/mL) exposure. Control vs low doses: 0.02 mg/mL PS-MPs. (B) OPLS-DA of control (green color) and 0.02 mg/mL PS-MPs (red color). (C) Permutation test statistics with R2Y 0.99 and Q2 0.67. (D) The result of random forest classification with an out-of-bag (OOB) error of 0.33 and overall accuracy of 67% of control vs 0.02 mg/mL PS-MPs-treated groups. (E) VIP score plot. (F) Univariate analysis showing the significant metabolites in the control and PS-MPs (0.02 mg/mL)-treated group detected by 1 H NMR spectroscopy. The x -axis represents the metabolite, and the y -axis shows the relative concentration when control (represented by green color) and PS-MPs, 0.02 mg/mL (represented by red color), were compared. (G) Correlation heat map for the differential metabolites identified in the control vs PS-MPs (0.02 mg/mL) exposed group as calculated by z -scores. (H) Pathway analysis indicated an impact factor less than 0.1, thus not very significant. Control vs high doses: 0.5 mg/mL PS-MPs. (I) OPLS-DA of control (green color) and 0.5 mg/mL PS-MPs concentration (red color). (J) Permutation test statistics with R2Y 1 and Q2 0.59. (K) The result of random forest classification with an out-of-bag (OOB) error of 0.0 and an overall accuracy of 100% of control vs 0.5 mg/mL PS-MPs-treated groups (L) VIP score plot. (M) Univariate analysis showing the significant metabolites in the control and PS-MPs (0.5 mg/mL)-treated group detected by 1 H NMR spectroscopy. The x -axis represents the metabolite, and the y -axis represents the relative concentration when control (represented by green color) and PS-MPs (0.5 mg/mL, represented by red color) were compared. (N) Correlation heat map for the differential metabolites identified in control vs PS-MPs (0.5 mg/mL)-exposed group, as calculated by z-scores. (O) Pathway analysis showing an impact factor of more than 0.1 was considered. The top red one is phenylalanine, tyrosine, and tryptophan biosynthesis, and the other, with an impact factor between 0.2 and 0.4 is phenylalanine metabolism.
Sigmaxl V8.1, supplied by SigmaXL Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nmr+suite+professional+software+package+%28v8%2E1/pmc07215279-125-7-4?v=SigmaXL+Inc
Average 90 stars, based on 1 article reviews
sigmaxl v8.1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
facsdiva v 8.1  (Becton Dickinson)
90
Becton Dickinson facsdiva v 8.1
<t>NMR-based</t> metabolomic perturbation in NRK-52E cells after 96 h of PS-MPs treatment at low doses, 0.02, and high doses, 0.5 mg/mL. Control vs low doses: 0.02 mg/mL PS-MPs. (A) Representative 1 H NMR spectrum <t>of</t> <t>metabolites</t> extracted from control and PS-MPs (0.02 and 1 mg/mL) exposure. Control vs low doses: 0.02 mg/mL PS-MPs. (B) OPLS-DA of control (green color) and 0.02 mg/mL PS-MPs (red color). (C) Permutation test statistics with R2Y 0.99 and Q2 0.67. (D) The result of random forest classification with an out-of-bag (OOB) error of 0.33 and overall accuracy of 67% of control vs 0.02 mg/mL PS-MPs-treated groups. (E) VIP score plot. (F) Univariate analysis showing the significant metabolites in the control and PS-MPs (0.02 mg/mL)-treated group detected by 1 H NMR spectroscopy. The x -axis represents the metabolite, and the y -axis shows the relative concentration when control (represented by green color) and PS-MPs, 0.02 mg/mL (represented by red color), were compared. (G) Correlation heat map for the differential metabolites identified in the control vs PS-MPs (0.02 mg/mL) exposed group as calculated by z -scores. (H) Pathway analysis indicated an impact factor less than 0.1, thus not very significant. Control vs high doses: 0.5 mg/mL PS-MPs. (I) OPLS-DA of control (green color) and 0.5 mg/mL PS-MPs concentration (red color). (J) Permutation test statistics with R2Y 1 and Q2 0.59. (K) The result of random forest classification with an out-of-bag (OOB) error of 0.0 and an overall accuracy of 100% of control vs 0.5 mg/mL PS-MPs-treated groups (L) VIP score plot. (M) Univariate analysis showing the significant metabolites in the control and PS-MPs (0.5 mg/mL)-treated group detected by 1 H NMR spectroscopy. The x -axis represents the metabolite, and the y -axis represents the relative concentration when control (represented by green color) and PS-MPs (0.5 mg/mL, represented by red color) were compared. (N) Correlation heat map for the differential metabolites identified in control vs PS-MPs (0.5 mg/mL)-exposed group, as calculated by z-scores. (O) Pathway analysis showing an impact factor of more than 0.1 was considered. The top red one is phenylalanine, tyrosine, and tryptophan biosynthesis, and the other, with an impact factor between 0.2 and 0.4 is phenylalanine metabolism.
Facsdiva V 8.1, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nmr+suite+professional+software+package+%28v8%2E1/pmc07302973-114-5-4?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
facsdiva v 8.1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
v 8.1 sr1 2009  (OriginLab corp)
90
OriginLab corp v 8.1 sr1 2009
<t>NMR-based</t> metabolomic perturbation in NRK-52E cells after 96 h of PS-MPs treatment at low doses, 0.02, and high doses, 0.5 mg/mL. Control vs low doses: 0.02 mg/mL PS-MPs. (A) Representative 1 H NMR spectrum <t>of</t> <t>metabolites</t> extracted from control and PS-MPs (0.02 and 1 mg/mL) exposure. Control vs low doses: 0.02 mg/mL PS-MPs. (B) OPLS-DA of control (green color) and 0.02 mg/mL PS-MPs (red color). (C) Permutation test statistics with R2Y 0.99 and Q2 0.67. (D) The result of random forest classification with an out-of-bag (OOB) error of 0.33 and overall accuracy of 67% of control vs 0.02 mg/mL PS-MPs-treated groups. (E) VIP score plot. (F) Univariate analysis showing the significant metabolites in the control and PS-MPs (0.02 mg/mL)-treated group detected by 1 H NMR spectroscopy. The x -axis represents the metabolite, and the y -axis shows the relative concentration when control (represented by green color) and PS-MPs, 0.02 mg/mL (represented by red color), were compared. (G) Correlation heat map for the differential metabolites identified in the control vs PS-MPs (0.02 mg/mL) exposed group as calculated by z -scores. (H) Pathway analysis indicated an impact factor less than 0.1, thus not very significant. Control vs high doses: 0.5 mg/mL PS-MPs. (I) OPLS-DA of control (green color) and 0.5 mg/mL PS-MPs concentration (red color). (J) Permutation test statistics with R2Y 1 and Q2 0.59. (K) The result of random forest classification with an out-of-bag (OOB) error of 0.0 and an overall accuracy of 100% of control vs 0.5 mg/mL PS-MPs-treated groups (L) VIP score plot. (M) Univariate analysis showing the significant metabolites in the control and PS-MPs (0.5 mg/mL)-treated group detected by 1 H NMR spectroscopy. The x -axis represents the metabolite, and the y -axis represents the relative concentration when control (represented by green color) and PS-MPs (0.5 mg/mL, represented by red color) were compared. (N) Correlation heat map for the differential metabolites identified in control vs PS-MPs (0.5 mg/mL)-exposed group, as calculated by z-scores. (O) Pathway analysis showing an impact factor of more than 0.1 was considered. The top red one is phenylalanine, tyrosine, and tryptophan biosynthesis, and the other, with an impact factor between 0.2 and 0.4 is phenylalanine metabolism.
V 8.1 Sr1 2009, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nmr+suite+professional+software+package+%28v8%2E1/10__1590_slash_1981___6723__2014-68-21-19?v=OriginLab+corp
Average 90 stars, based on 1 article reviews
v 8.1 sr1 2009 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
celera assembler v8.1  (Celera)
90
Celera celera assembler v8.1
<t>NMR-based</t> metabolomic perturbation in NRK-52E cells after 96 h of PS-MPs treatment at low doses, 0.02, and high doses, 0.5 mg/mL. Control vs low doses: 0.02 mg/mL PS-MPs. (A) Representative 1 H NMR spectrum <t>of</t> <t>metabolites</t> extracted from control and PS-MPs (0.02 and 1 mg/mL) exposure. Control vs low doses: 0.02 mg/mL PS-MPs. (B) OPLS-DA of control (green color) and 0.02 mg/mL PS-MPs (red color). (C) Permutation test statistics with R2Y 0.99 and Q2 0.67. (D) The result of random forest classification with an out-of-bag (OOB) error of 0.33 and overall accuracy of 67% of control vs 0.02 mg/mL PS-MPs-treated groups. (E) VIP score plot. (F) Univariate analysis showing the significant metabolites in the control and PS-MPs (0.02 mg/mL)-treated group detected by 1 H NMR spectroscopy. The x -axis represents the metabolite, and the y -axis shows the relative concentration when control (represented by green color) and PS-MPs, 0.02 mg/mL (represented by red color), were compared. (G) Correlation heat map for the differential metabolites identified in the control vs PS-MPs (0.02 mg/mL) exposed group as calculated by z -scores. (H) Pathway analysis indicated an impact factor less than 0.1, thus not very significant. Control vs high doses: 0.5 mg/mL PS-MPs. (I) OPLS-DA of control (green color) and 0.5 mg/mL PS-MPs concentration (red color). (J) Permutation test statistics with R2Y 1 and Q2 0.59. (K) The result of random forest classification with an out-of-bag (OOB) error of 0.0 and an overall accuracy of 100% of control vs 0.5 mg/mL PS-MPs-treated groups (L) VIP score plot. (M) Univariate analysis showing the significant metabolites in the control and PS-MPs (0.5 mg/mL)-treated group detected by 1 H NMR spectroscopy. The x -axis represents the metabolite, and the y -axis represents the relative concentration when control (represented by green color) and PS-MPs (0.5 mg/mL, represented by red color) were compared. (N) Correlation heat map for the differential metabolites identified in control vs PS-MPs (0.5 mg/mL)-exposed group, as calculated by z-scores. (O) Pathway analysis showing an impact factor of more than 0.1 was considered. The top red one is phenylalanine, tyrosine, and tryptophan biosynthesis, and the other, with an impact factor between 0.2 and 0.4 is phenylalanine metabolism.
Celera Assembler V8.1, supplied by Celera, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nmr+suite+professional+software+package+%28v8%2E1/pmc06588369-17-24-23?v=Celera
Average 90 stars, based on 1 article reviews
celera assembler v8.1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
non-linear regression analysis with origin v.8.1  (OriginLab corp)
90
OriginLab corp non-linear regression analysis with origin v.8.1
<t>NMR-based</t> metabolomic perturbation in NRK-52E cells after 96 h of PS-MPs treatment at low doses, 0.02, and high doses, 0.5 mg/mL. Control vs low doses: 0.02 mg/mL PS-MPs. (A) Representative 1 H NMR spectrum <t>of</t> <t>metabolites</t> extracted from control and PS-MPs (0.02 and 1 mg/mL) exposure. Control vs low doses: 0.02 mg/mL PS-MPs. (B) OPLS-DA of control (green color) and 0.02 mg/mL PS-MPs (red color). (C) Permutation test statistics with R2Y 0.99 and Q2 0.67. (D) The result of random forest classification with an out-of-bag (OOB) error of 0.33 and overall accuracy of 67% of control vs 0.02 mg/mL PS-MPs-treated groups. (E) VIP score plot. (F) Univariate analysis showing the significant metabolites in the control and PS-MPs (0.02 mg/mL)-treated group detected by 1 H NMR spectroscopy. The x -axis represents the metabolite, and the y -axis shows the relative concentration when control (represented by green color) and PS-MPs, 0.02 mg/mL (represented by red color), were compared. (G) Correlation heat map for the differential metabolites identified in the control vs PS-MPs (0.02 mg/mL) exposed group as calculated by z -scores. (H) Pathway analysis indicated an impact factor less than 0.1, thus not very significant. Control vs high doses: 0.5 mg/mL PS-MPs. (I) OPLS-DA of control (green color) and 0.5 mg/mL PS-MPs concentration (red color). (J) Permutation test statistics with R2Y 1 and Q2 0.59. (K) The result of random forest classification with an out-of-bag (OOB) error of 0.0 and an overall accuracy of 100% of control vs 0.5 mg/mL PS-MPs-treated groups (L) VIP score plot. (M) Univariate analysis showing the significant metabolites in the control and PS-MPs (0.5 mg/mL)-treated group detected by 1 H NMR spectroscopy. The x -axis represents the metabolite, and the y -axis represents the relative concentration when control (represented by green color) and PS-MPs (0.5 mg/mL, represented by red color) were compared. (N) Correlation heat map for the differential metabolites identified in control vs PS-MPs (0.5 mg/mL)-exposed group, as calculated by z-scores. (O) Pathway analysis showing an impact factor of more than 0.1 was considered. The top red one is phenylalanine, tyrosine, and tryptophan biosynthesis, and the other, with an impact factor between 0.2 and 0.4 is phenylalanine metabolism.
Non Linear Regression Analysis With Origin V.8.1, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nmr+suite+professional+software+package+%28v8%2E1/pmc03810028-201-10-12?v=OriginLab+corp
Average 90 stars, based on 1 article reviews
non-linear regression analysis with origin v.8.1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
admet predictor v 8.1  (ADMET Predictor)
90
ADMET Predictor admet predictor v 8.1
<t>NMR-based</t> metabolomic perturbation in NRK-52E cells after 96 h of PS-MPs treatment at low doses, 0.02, and high doses, 0.5 mg/mL. Control vs low doses: 0.02 mg/mL PS-MPs. (A) Representative 1 H NMR spectrum <t>of</t> <t>metabolites</t> extracted from control and PS-MPs (0.02 and 1 mg/mL) exposure. Control vs low doses: 0.02 mg/mL PS-MPs. (B) OPLS-DA of control (green color) and 0.02 mg/mL PS-MPs (red color). (C) Permutation test statistics with R2Y 0.99 and Q2 0.67. (D) The result of random forest classification with an out-of-bag (OOB) error of 0.33 and overall accuracy of 67% of control vs 0.02 mg/mL PS-MPs-treated groups. (E) VIP score plot. (F) Univariate analysis showing the significant metabolites in the control and PS-MPs (0.02 mg/mL)-treated group detected by 1 H NMR spectroscopy. The x -axis represents the metabolite, and the y -axis shows the relative concentration when control (represented by green color) and PS-MPs, 0.02 mg/mL (represented by red color), were compared. (G) Correlation heat map for the differential metabolites identified in the control vs PS-MPs (0.02 mg/mL) exposed group as calculated by z -scores. (H) Pathway analysis indicated an impact factor less than 0.1, thus not very significant. Control vs high doses: 0.5 mg/mL PS-MPs. (I) OPLS-DA of control (green color) and 0.5 mg/mL PS-MPs concentration (red color). (J) Permutation test statistics with R2Y 1 and Q2 0.59. (K) The result of random forest classification with an out-of-bag (OOB) error of 0.0 and an overall accuracy of 100% of control vs 0.5 mg/mL PS-MPs-treated groups (L) VIP score plot. (M) Univariate analysis showing the significant metabolites in the control and PS-MPs (0.5 mg/mL)-treated group detected by 1 H NMR spectroscopy. The x -axis represents the metabolite, and the y -axis represents the relative concentration when control (represented by green color) and PS-MPs (0.5 mg/mL, represented by red color) were compared. (N) Correlation heat map for the differential metabolites identified in control vs PS-MPs (0.5 mg/mL)-exposed group, as calculated by z-scores. (O) Pathway analysis showing an impact factor of more than 0.1 was considered. The top red one is phenylalanine, tyrosine, and tryptophan biosynthesis, and the other, with an impact factor between 0.2 and 0.4 is phenylalanine metabolism.
Admet Predictor V 8.1, supplied by ADMET Predictor, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nmr+suite+professional+software+package+%28v8%2E1/pmc07965836-29-9-9?v=ADMET+Predictor
Average 90 stars, based on 1 article reviews
admet predictor v 8.1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
genstat v 8.1  (vsn international)
90
vsn international genstat v 8.1
<t>NMR-based</t> metabolomic perturbation in NRK-52E cells after 96 h of PS-MPs treatment at low doses, 0.02, and high doses, 0.5 mg/mL. Control vs low doses: 0.02 mg/mL PS-MPs. (A) Representative 1 H NMR spectrum <t>of</t> <t>metabolites</t> extracted from control and PS-MPs (0.02 and 1 mg/mL) exposure. Control vs low doses: 0.02 mg/mL PS-MPs. (B) OPLS-DA of control (green color) and 0.02 mg/mL PS-MPs (red color). (C) Permutation test statistics with R2Y 0.99 and Q2 0.67. (D) The result of random forest classification with an out-of-bag (OOB) error of 0.33 and overall accuracy of 67% of control vs 0.02 mg/mL PS-MPs-treated groups. (E) VIP score plot. (F) Univariate analysis showing the significant metabolites in the control and PS-MPs (0.02 mg/mL)-treated group detected by 1 H NMR spectroscopy. The x -axis represents the metabolite, and the y -axis shows the relative concentration when control (represented by green color) and PS-MPs, 0.02 mg/mL (represented by red color), were compared. (G) Correlation heat map for the differential metabolites identified in the control vs PS-MPs (0.02 mg/mL) exposed group as calculated by z -scores. (H) Pathway analysis indicated an impact factor less than 0.1, thus not very significant. Control vs high doses: 0.5 mg/mL PS-MPs. (I) OPLS-DA of control (green color) and 0.5 mg/mL PS-MPs concentration (red color). (J) Permutation test statistics with R2Y 1 and Q2 0.59. (K) The result of random forest classification with an out-of-bag (OOB) error of 0.0 and an overall accuracy of 100% of control vs 0.5 mg/mL PS-MPs-treated groups (L) VIP score plot. (M) Univariate analysis showing the significant metabolites in the control and PS-MPs (0.5 mg/mL)-treated group detected by 1 H NMR spectroscopy. The x -axis represents the metabolite, and the y -axis represents the relative concentration when control (represented by green color) and PS-MPs (0.5 mg/mL, represented by red color) were compared. (N) Correlation heat map for the differential metabolites identified in control vs PS-MPs (0.5 mg/mL)-exposed group, as calculated by z-scores. (O) Pathway analysis showing an impact factor of more than 0.1 was considered. The top red one is phenylalanine, tyrosine, and tryptophan biosynthesis, and the other, with an impact factor between 0.2 and 0.4 is phenylalanine metabolism.
Genstat V 8.1, supplied by vsn international, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nmr+suite+professional+software+package+%28v8%2E1/10__1071_slash_fp09257-100-11-14?v=vsn+international
Average 90 stars, based on 1 article reviews
genstat v 8.1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
matinspector v. 8.1  (Genomatix gmbh)
90
Genomatix gmbh matinspector v. 8.1
<t>NMR-based</t> metabolomic perturbation in NRK-52E cells after 96 h of PS-MPs treatment at low doses, 0.02, and high doses, 0.5 mg/mL. Control vs low doses: 0.02 mg/mL PS-MPs. (A) Representative 1 H NMR spectrum <t>of</t> <t>metabolites</t> extracted from control and PS-MPs (0.02 and 1 mg/mL) exposure. Control vs low doses: 0.02 mg/mL PS-MPs. (B) OPLS-DA of control (green color) and 0.02 mg/mL PS-MPs (red color). (C) Permutation test statistics with R2Y 0.99 and Q2 0.67. (D) The result of random forest classification with an out-of-bag (OOB) error of 0.33 and overall accuracy of 67% of control vs 0.02 mg/mL PS-MPs-treated groups. (E) VIP score plot. (F) Univariate analysis showing the significant metabolites in the control and PS-MPs (0.02 mg/mL)-treated group detected by 1 H NMR spectroscopy. The x -axis represents the metabolite, and the y -axis shows the relative concentration when control (represented by green color) and PS-MPs, 0.02 mg/mL (represented by red color), were compared. (G) Correlation heat map for the differential metabolites identified in the control vs PS-MPs (0.02 mg/mL) exposed group as calculated by z -scores. (H) Pathway analysis indicated an impact factor less than 0.1, thus not very significant. Control vs high doses: 0.5 mg/mL PS-MPs. (I) OPLS-DA of control (green color) and 0.5 mg/mL PS-MPs concentration (red color). (J) Permutation test statistics with R2Y 1 and Q2 0.59. (K) The result of random forest classification with an out-of-bag (OOB) error of 0.0 and an overall accuracy of 100% of control vs 0.5 mg/mL PS-MPs-treated groups (L) VIP score plot. (M) Univariate analysis showing the significant metabolites in the control and PS-MPs (0.5 mg/mL)-treated group detected by 1 H NMR spectroscopy. The x -axis represents the metabolite, and the y -axis represents the relative concentration when control (represented by green color) and PS-MPs (0.5 mg/mL, represented by red color) were compared. (N) Correlation heat map for the differential metabolites identified in control vs PS-MPs (0.5 mg/mL)-exposed group, as calculated by z-scores. (O) Pathway analysis showing an impact factor of more than 0.1 was considered. The top red one is phenylalanine, tyrosine, and tryptophan biosynthesis, and the other, with an impact factor between 0.2 and 0.4 is phenylalanine metabolism.
Matinspector V. 8.1, supplied by Genomatix gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nmr+suite+professional+software+package+%28v8%2E1/pmc04981614-76-34-37?v=Genomatix+gmbh
Average 90 stars, based on 1 article reviews
matinspector v. 8.1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


NMR-based metabolomic perturbation in NRK-52E cells after 96 h of PS-MPs treatment at low doses, 0.02, and high doses, 0.5 mg/mL. Control vs low doses: 0.02 mg/mL PS-MPs. (A) Representative 1 H NMR spectrum of metabolites extracted from control and PS-MPs (0.02 and 1 mg/mL) exposure. Control vs low doses: 0.02 mg/mL PS-MPs. (B) OPLS-DA of control (green color) and 0.02 mg/mL PS-MPs (red color). (C) Permutation test statistics with R2Y 0.99 and Q2 0.67. (D) The result of random forest classification with an out-of-bag (OOB) error of 0.33 and overall accuracy of 67% of control vs 0.02 mg/mL PS-MPs-treated groups. (E) VIP score plot. (F) Univariate analysis showing the significant metabolites in the control and PS-MPs (0.02 mg/mL)-treated group detected by 1 H NMR spectroscopy. The x -axis represents the metabolite, and the y -axis shows the relative concentration when control (represented by green color) and PS-MPs, 0.02 mg/mL (represented by red color), were compared. (G) Correlation heat map for the differential metabolites identified in the control vs PS-MPs (0.02 mg/mL) exposed group as calculated by z -scores. (H) Pathway analysis indicated an impact factor less than 0.1, thus not very significant. Control vs high doses: 0.5 mg/mL PS-MPs. (I) OPLS-DA of control (green color) and 0.5 mg/mL PS-MPs concentration (red color). (J) Permutation test statistics with R2Y 1 and Q2 0.59. (K) The result of random forest classification with an out-of-bag (OOB) error of 0.0 and an overall accuracy of 100% of control vs 0.5 mg/mL PS-MPs-treated groups (L) VIP score plot. (M) Univariate analysis showing the significant metabolites in the control and PS-MPs (0.5 mg/mL)-treated group detected by 1 H NMR spectroscopy. The x -axis represents the metabolite, and the y -axis represents the relative concentration when control (represented by green color) and PS-MPs (0.5 mg/mL, represented by red color) were compared. (N) Correlation heat map for the differential metabolites identified in control vs PS-MPs (0.5 mg/mL)-exposed group, as calculated by z-scores. (O) Pathway analysis showing an impact factor of more than 0.1 was considered. The top red one is phenylalanine, tyrosine, and tryptophan biosynthesis, and the other, with an impact factor between 0.2 and 0.4 is phenylalanine metabolism.

Journal: ACS Omega

Article Title: Polystyrene Microplastics Activate Noncanonical TGF‑β Signaling and Metabolomic Reprogramming to Promote Epithelial-Mesenchymal Transition and Fibrosis in the Kidney

doi: 10.1021/acsomega.5c10834

Figure Lengend Snippet: NMR-based metabolomic perturbation in NRK-52E cells after 96 h of PS-MPs treatment at low doses, 0.02, and high doses, 0.5 mg/mL. Control vs low doses: 0.02 mg/mL PS-MPs. (A) Representative 1 H NMR spectrum of metabolites extracted from control and PS-MPs (0.02 and 1 mg/mL) exposure. Control vs low doses: 0.02 mg/mL PS-MPs. (B) OPLS-DA of control (green color) and 0.02 mg/mL PS-MPs (red color). (C) Permutation test statistics with R2Y 0.99 and Q2 0.67. (D) The result of random forest classification with an out-of-bag (OOB) error of 0.33 and overall accuracy of 67% of control vs 0.02 mg/mL PS-MPs-treated groups. (E) VIP score plot. (F) Univariate analysis showing the significant metabolites in the control and PS-MPs (0.02 mg/mL)-treated group detected by 1 H NMR spectroscopy. The x -axis represents the metabolite, and the y -axis shows the relative concentration when control (represented by green color) and PS-MPs, 0.02 mg/mL (represented by red color), were compared. (G) Correlation heat map for the differential metabolites identified in the control vs PS-MPs (0.02 mg/mL) exposed group as calculated by z -scores. (H) Pathway analysis indicated an impact factor less than 0.1, thus not very significant. Control vs high doses: 0.5 mg/mL PS-MPs. (I) OPLS-DA of control (green color) and 0.5 mg/mL PS-MPs concentration (red color). (J) Permutation test statistics with R2Y 1 and Q2 0.59. (K) The result of random forest classification with an out-of-bag (OOB) error of 0.0 and an overall accuracy of 100% of control vs 0.5 mg/mL PS-MPs-treated groups (L) VIP score plot. (M) Univariate analysis showing the significant metabolites in the control and PS-MPs (0.5 mg/mL)-treated group detected by 1 H NMR spectroscopy. The x -axis represents the metabolite, and the y -axis represents the relative concentration when control (represented by green color) and PS-MPs (0.5 mg/mL, represented by red color) were compared. (N) Correlation heat map for the differential metabolites identified in control vs PS-MPs (0.5 mg/mL)-exposed group, as calculated by z-scores. (O) Pathway analysis showing an impact factor of more than 0.1 was considered. The top red one is phenylalanine, tyrosine, and tryptophan biosynthesis, and the other, with an impact factor between 0.2 and 0.4 is phenylalanine metabolism.

Article Snippet: Manual baseline correction (Whittaker method) was done with a Chenomx NMR processor (NMR Suite, v8.1, Chenomx Inc., Canada), and peak fitting of metabolites was done using the Chenomx profiler.

Techniques: Metabolomic, Control, Structural Proteomics, Concentration Assay